ArticleBMC pregnancy and childbirth2025
The prevalence and risk factors of vaginal Candida species and group B Streptococcus colonization in pregnant women attending antenatal care at Hawassa university comprehensive specialized hospital in Hawassa City, Southern Ethiopia.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Species Distribution ofPathogens (Basel, Switzerland) · 2026Article
- Non-albicans Candida vaginal infections in sub-Saharan Africa: a systematic review, meta-analysis, and narrative synthesis of prevalence, antifungal resistance, and clinical implications among women of reproductive age.Tropical medicine and health · 2026Review
- Culture-Based Cervicovaginal Findings andMedicina (Kaunas, Lithuania) · 2026Observational
- Candida urinary tract infections, antifungal susceptibility and factors associated with candiduria among pregnant women seeking antenatal care at Murang'a County Referral Hospital, Kenya.BMC pregnancy and childbirth · 2026Article
- Advances in vulvovaginal candidiasis research: a comprehensive review from epidemiology, diagnosis, treatment to resistance mechanisms.Frontiers in microbiology · 2026Review
- Prevalence of urinary tract infections and antibiotic susceptibility patterns of bacterial isolates in first-time ANC attendees at a secondary health facility in Ghana: a cross-sectional study.BMC pregnancy and childbirth · 2025Article
- Comprehensive analysis of vaginal microbiota, metabolites, and inflammatory factors in preterm and term pregnancies.Frontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe global prevalence of vaginal candidiasis and group B streptococcus (GBS) colonization among pregnant women is significant and these pathogens are associated with adverse maternal and neonatal outcomes, including preterm birth, stillbirth, and neonatal infections.
objectiveThis study aimed to determine the magnitude and risk factors for vaginal Candida and GBS in pregnant women who were attending antenatal care at Hawassa University Compressive Specialized Hospital from July October 2021.
methodA Hospital-based, cross-sectional study was conducted using microscopy, culture, germ tube, and biochemical tests on vaginal swab samples from 110 volunteer pregnant women. A structured questionnaire was used to collect data on perceived risk factors. Data was analyzed using SPSS version 22, and an odds ratio at a 95% confidence interval with p < 0.05 was used to interpret the risk factors.
resultsCandida species was identified in 33 (30%) pregnant women, whereas, GBS colonization was not detected in any of them. Of the vaginal Candida species, 17 (51.52%) were Candida albicans and 16 (48.48%) were non-albicans Candida. Symptomatic vaginal candidiasis was diagnosed in only four women. The most important predictors of vaginal Candida colonization were parity of two and underwear replacement once a day.
conclusionBased on these findings, screening for vaginal candidiasis and prophylactic treatment should be considered for young, multiparous, pregnant women in their third trimester, if supported clinically.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.